CDH13 and RIL (PDLIM4) expression levels were significantly decreased in lymph node metastasis, whereas no significantly changes in the expression of RASSF1A, RARβ2 and CDH1 mRNAs were observed. The gene discussed is CDH13; the disease is metastatic malignant neoplasm in the lymph nodes.